Tuesday, March 24, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Standardize Medicine by Law

Daily Remedy by Daily Remedy
July 10, 2022
in Politics & Law
0
Standardize Medicine by Law

Modern healthcare is effectively a legal entity, in which legal rulings define the standards of care. Therefore, the interpretations of law reflect how well the legal standards represent good clinical care – as legal trends in court dictate clinical trends in patient care. The rise in opioid litigation during the epidemic has given commensurate rise to several medically harmful legal interpretations, with each case reinforcing a dangerous trend of restricting medically necessary opioids to patients. There have been thousands of civil lawsuits and criminal cases, each with its own spin on the purpose of opioids in healthcare, each attempting to adjudicate the morality of addiction through legal means, each reinterpreting healthcare laws and statutes to focus on specific social concerns over the rights of individual patients.

In theory, each legal case should be deliberated to the fullest extent required. In reality, the legal system operates through a series of default tendencies, attempting to balance administrative burdens with the individual considerations of each case. It often dissolves into a series of default procedural motions in which cases are hurried through and addressed as efficiently as possible.

Healthcare behavior is a mix of medical knowledge and real time decision-making with limited information. Healthcare law attempts to standardize this behavior, leading to inevitable simplifications. As a result, the original intent of the law and its implementation separate, widening the scope for legal reinterpretation.

Many courts lack a standardized framework to evaluate complex healthcare behaviors. Absent such a framework, each court determines what clinical information merits review and which clinical aspects of the patient encounter apply to the legal proceedings. Eventually, different courts establish different interpretations of healthcare law based on the cases presented. These variations predispose and eventually reinforce extreme legal interpretations of healthcare law, as they are the simplest interpretation and therefore the most likely default decision.

Behavioral economists studying biases that arise from default tendencies have found that even subtle differences in default reactions produce wide variability in outcomes. A judge who defaults to studying all aspects of healthcare behavior might have a different perspective than a judge who defaults to passing such work onto law clerks.

Ironically, we find that information overload adversely affects judicial decision making. This counterintuitive notion has been observed in multiple studies that show judges make more accurate risk assessments to grant bail when they have less information about the defendant. The decision to grant bail is a skill acquired from years of experience – a skill that no longer applies when judges face unique, specialized cases with unfamiliar, complex variables, as in many healthcare cases. This makes the prevalence of misinformation in the opioid epidemic particularly pernicious as it has overwhelmed the courts with bias.

Most judges are not comfortable processing all the variables in specialized healthcare cases. As a result, judges rely on default tendencies. Since most judges delegate decision-making requiring greater subject expertise, additional medical education also gets delegated – to individuals who forego the nuanced distinctions that define healthcare behavior in favor of default decisions.

We think of the legal system through the eyes of a judge. But the courts are more than that. Each judicial system features an entire administration of probation officers and law clerks. Judges even rely on prosecutors for guidance on healthcare, revealing a familiarity bias within the court that predisposes law clerks to seek guidance from prosecutors, who are motivated to convict defendants.

The legal system abhors uncertainty, and over the many opioid cases in recent years, prosecutors have instilled a simplified narrative, using it as legal precedent to expedite judicial review, and thereby exacerbating the disparity between intent and implementation of opioid laws.

Alexander Hamilton said that the heart of society is the fairness of the courts and their ability to balance power with purpose, with judges serving as symbols of justice. But how can we trust judges to be fair and equitable – to ensure that opioid laws apply equally – when each court has a wide range of default tendencies?

Many legal cases rely on earlier rulings that are perceived to be similar, called bellwether cases, to frame legal arguments. The earliest cases in the opioid epidemic standardized the interpretations of the law and the extent to which clinical context is considered. Reiterated enough times, these formed the template for many prosecutorial arguments in high-profile opioid cases.

This phenomenon, known as legal fluency, is like a wave that builds on each ruling, growing stronger by the case. But in aggregating legal arguments, not all cases receive equal consideration. And certain biases or default tendencies that are present in bellwether cases become overrepresented in later cases.

Satirist Chuck Klosterman says that “laws are deliberately complicated to allow multiple interpretations,” but for all the variations and interpretations we see in law, its application is far more uniform and dependent on bellwether cases. If these bellwether cases introduce legal interpretations harmful to patient care, then the application of opioid laws will reinforce these harmful clinical standards.

In 2019, the Oklahoma attorney general orchestrated a landmark settlement (since overturned) against Johnson & Johnson for their role in manufacturing opioids, citing public nuisance ordinance laws as the basis of the lawsuit. These laws were never intended to be used in such a way. But once the precedent formed to interpret ordinance laws against opioid manufacturers, it was repeated in courts across the country. Ironically, Oklahoma’s opioid epidemic is dwarfed by the state’s methamphetamine, cocaine, and alcohol epidemics. And state representatives involved in the case plan to use funds from the opioid settlement for rehabilitative services that involve other illicit substances. So, while the Oklahoma courts view this case as a victory against corporate malfeasance, the state’s medical community views it as a financial windfall that can address more pressing addiction concerns.

Many high-profile lawsuits appear sound in principle, but in practice these settlements have shown glaring limitations in the courts’ ability to allocate settlement funds, as early efforts to disseminate funds have run into conflicts between state and local authorities, with each claiming to be better suited to manage them. In Cuyahoga County, Ohio, an opioid settlement resolved more than two thousand opioid lawsuits, becoming a bellwether case for settlements throughout the country. As part of the settlement, pharmaceutical firms will finance and distribute opioid abuse medications to patients. This was already happening, with the only difference being that the corporations finance the medications instead of state and federal healthcare insurance plans.

But once the settlement dollars were garnered, the apparent unified legal stance quickly fell apart. State governments believe they are better equipped to handle the medical issues underlying the opioid epidemic through wide-ranging healthcare policies. Local entities complain that the distribution of funds should reflect specific addiction needs within each community, something only local officials can understand. These differences in legal arguments, which were glossed over when arguing the broad class action lawsuit, now form the crux of the disagreements between different government entities.

The opioid epidemic is far too complex to simplify in one legal mandate and has affected different parts of the country in different ways. It cannot be solved through traditional legal means or common litigation strategies. Yet the same legal tactics – be it class action lawsuits or criminal cases against pharmaceutical, drug distribution, or drug manufacturing companies – is used in nearly every major opioid settlement cases. Prosecutors first targeted smaller pharmaceutical companies, knowing they would be more likely to settle or plea. Subsequently, prosecutors use the initial cases to serve as precedent to strengthen the legal case against larger pharmaceutical companies, who also eventually settled. The enormity of the cases together overshadows the validity of each individual case.

When the courts reinforce extreme, medically harmful interpretations of the law brought forth by prosecutors, the judge’s interpretations become the standard of clinical care and reference point for future litigation. The default legal tendencies that appear in class-action lawsuits then mirror the default tendencies in individual criminal cases against providers. Whenever the CSA is applied to a healthcare provider, the accused physician or pharmacist nearly always accepts a plea deal, further shifting the legal system away from medically appropriate interpretations of the law and toward reflexive convictions. The accused is left to choose between guilt and innocence, each of which is an oversimplified interpretation of the law devoid of any clinical context, and rife with a bias known as the halo effect, in which people are seen to be entirely good or entirely bad. But the very nuances and intricacies that are ignored in courts are what define clinical care.

Settling cases without arguing the validity of the arguments or the underlying clinical context has accelerated the trend of medically harmful court rulings, paving the way for legal fluencies that reinforce extreme interpretations of the law and effectively enable predetermined legal outcomes that are harmful to patients.

By shifting healthcare law toward pleas and settlements, we shift it into an unnatural state of simplicity in which any deviation is met with a skeptical eye and with a risk of criminal repercussions. Legal arguments no longer require meeting the standards of reasonable doubt, nor even to be medically appropriate. Merely presenting an argument, and effectively using court machinations to proceed with it, has allowed even substandard arguments to become legal victories for prosecutors. But these extreme interpretations of healthcare law have created an interpretive tunnel vision that substitutes the complexity of medical behavior for the fluency of legal precedent.

It should come as no surprise that the opioid epidemic worsened during the Covid-19 pandemic. The combination of acute mental health crises with diminished access to care worsened the quality of life for those already struggling with addiction, leading to a slew of overdoses in its wake.

We cannot solve the opioid epidemic with the legal system as it is presently constructed. If we continue to rely on the same legal tactics, default tendencies, and contrived legal interpretations, then the epidemic will only worsen.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 0

  1. Brian says:
    4 years ago

    Thanks

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices.

 key  topics

Deceptive pricing strategies in healthcare
The role of brand perception and pricing manipulation
The concept of drip pricing and hidden costs
The rise of healthcare consumerism and patient agency
Strategies for patients to identify and avoid deceptive practices

Chapters

00:00 The Evolution of the GLP-1 Telemedicine Market
01:12 How Pricing Is Obscured and Perceived Discounts Are Created
02:11 TrumpRx: Coupon Aggregator or Discount Store?
03:12 Why Price Deception Thrives in Healthcare
04:12 The Membership Fee Illusion and Hidden Costs
05:10 Brand Recognition and Drip Pricing Strategies
06:17 The Impact of Brand and Anchor Pricing on Perceived Value
07:16 The Role of Price Drip Strategies in Healthcare Pricing
08:15 The Rise of Healthcare Consumerism and Patient Agency
09:14 How to Protect Yourself from Deceptive Pricing Practices
10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • A Generation in Distress: New CDC Findings Reveal Worsening Mental Health Among Teen Girls

    0 shares
    Share 0 Tweet 0
  • From Patient Advocate to Subject Matter Expert

    2 shares
    Share 0 Tweet 0
  • The Market Failure Inside the Petri Dish

    0 shares
    Share 0 Tweet 0
  • The Glycemic Mirror

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy